Search

[Display omitted] Ocular delivery is the most challenging aspect in the field of pharmaceutical research. The major hurdle for the controlled delivery of drugs to the eye includes the physiological static barriers such as the complex layers of the cornea, sclera and retina which restrict the drug from permeating into the anterior and posterior segments of the eye. Recent years have witnessed inventions in the field of conventional and nanocarrier drug delivery which have shown considerable enhancement in delivering small to large molecules across the eye. The dynamic challenges associated with conventional systems include limited drug contact time and inadequate ocular bioavailability resulting from solution drainage, tear turnover, and dilution or lacrimation. To this end, various bioactive-based nanosized carriers including liposomes, ethosomes, niosomes, dendrimer, nanogel, nanofibers, contact lenses, nanoprobes, selenium nanobells, nanosponge, polymeric micelles, silver nanoparticles, and gold nanoparticles among others have been developed to circumvent the limitations associated with the conventional dosage forms. These nanocarriers have been shown to achieve enhanced drug permeation or retention and prolong drug release in the ocular tissue due to their better tissue adherence. The surface charge and the size of nanocarriers (10–1000 nm) are the important key factors to overcome ocular barriers. Various nanocarriers have been shown to deliver active therapeutic molecules including timolol maleate, ampicillin, natamycin, voriconazole, cyclosporine A, dexamethasone, moxifloxacin, and fluconazole among others for the treatment of anterior and posterior eye diseases. Taken together, in a nutshell, this extensive review provides a comprehensive perspective on the numerous facets of ocular drug delivery with a special focus on bioactive nanocarrier-based approaches, including the difficulties and constraints involved in the fabrication of nanocarriers. This also provides the detailed invention, applications, biodistribution and safety-toxicity of nanocarriers-based therapeutcis for the ophthalmic delivery. [ABSTRACT FROM AUTHOR]

Ethnopharmacological relevance Several plants have been found to have effective against number of ophthalmological problems in Navarra. Material and methods Information was collected using semi-structured ethnobotanical interviews with 686 informants in 267 locations. In order to confirm the pharmacological application of the uses more cited by the informants, a literature review was conducted. Results A total of 57 pharmaceutical uses were reported, for 19 plants and 13 families, mainly represented by Asteraceae . The most frequently used parts were inflorescences, flowers, aerial parts, leaves and flowered aerial parts. The related affections fell into eleven categories: bloodshot eyes, watery eyes and wounds, improve vision, irrited eyelids, rheums and styes, tired eyes, conjunctivitis, eyewash, ocular problems in general. The most cited plants were: Chamaemelum nobile (L.) All., Santolina chamaecyparissus L. ssp. squarrosa (DC.) Nyman, Sambucus nigra L. ssp. nigra , Rosa agrestis Savi and Calendula officinalis L. None of them have been pharmacologically validated by Official International Organisms. From the therapeutic point of view, Allium sativum L., Foeniculum vulgare Mill., C. officinalis , and S. chamaecyparissus ssp. squarrosa deserve special attention, because ethnobotanical and pharmacological studies suggest that these medicinal plants are effective for ophthalmological problems. Conclusions The present study constitutes a good basis for further phytochemical and pharmacological research of these four plants, which could be of interest in the design of new inexpensive, effective and safe drugs. The remaining plants are needed to be screened through standard pharmacological and clinical procedures for their activities. [ABSTRACT FROM AUTHOR]

Abstract: The objective of this clinical study was to report the prevalence of ocular disorders in a large population of horses from the Indian army. Both eyes of 500 horses were examined using a direct ophthalmoscope and by a transillumination procedure. Intraocular pressures were measured in several study horses. Fluorescein dye, Schirmer tear test, and menace testing were performed when indicated. Corneal culture swabs were collected from horses affected with corneal ulcers found on ophthalmoscopic examination. A total of 100 horses were found to be affected with some form of ocular disorder. The eye problems recorded were congenital eye lid disorders (2%) and included a subcutaneous cyst in the lower eye lid and slit in upper eye lid; conjunctivitis (12%); chronic interstitial keratitis (30%); a parasite in the anterior chamber (1%), which was however not removed for genus and species identification; phthisis bulbi (1%); uveitis (24%); glaucoma (13%); cataracts (3%); unilateral retinal hemorrhage (1%); luxation of cataractous lens (3%); posterior synechia (2%); and corneal ulceration (8%). Pseudomonas spp was the most common bacteria identified in horses affected with corneal ulceration. Vision-threatening ocular disorders are high in Indian army horses; this is a cause of major concern for the rider and the horse and, therefore, it is important to include ocular examination in horses as part of a routine and complete physical examination. [Copyright &y& Elsevier]

Copyright of EMC-Oto-rhino-laryngologie is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)